Livforsakringsbolaget Skandia Omsesidigt Purchases 1,200 Shares of Intuitive Surgical, Inc. $ISRG

Livforsakringsbolaget Skandia Omsesidigt increased its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 14.0% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 9,743 shares of the medical equipment provider’s stock after acquiring an additional 1,200 shares during the quarter. Livforsakringsbolaget Skandia Omsesidigt’s holdings in Intuitive Surgical were worth $5,294,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also bought and sold shares of the stock. IFM Investors Pty Ltd increased its position in Intuitive Surgical by 5.6% during the second quarter. IFM Investors Pty Ltd now owns 72,714 shares of the medical equipment provider’s stock worth $39,514,000 after acquiring an additional 3,832 shares during the period. Oliver Lagore Vanvalin Investment Group bought a new position in Intuitive Surgical during the second quarter worth $1,138,000. Clare Market Investments LLC increased its position in Intuitive Surgical by 1.3% during the second quarter. Clare Market Investments LLC now owns 6,010 shares of the medical equipment provider’s stock worth $3,266,000 after acquiring an additional 78 shares during the period. Trust Point Inc. increased its position in Intuitive Surgical by 7.5% during the second quarter. Trust Point Inc. now owns 1,598 shares of the medical equipment provider’s stock worth $868,000 after acquiring an additional 112 shares during the period. Finally, Burns J W & Co. Inc. NY increased its position in Intuitive Surgical by 43.2% during the second quarter. Burns J W & Co. Inc. NY now owns 16,814 shares of the medical equipment provider’s stock worth $9,137,000 after acquiring an additional 5,075 shares during the period. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Stock Performance

Shares of NASDAQ:ISRG opened at $435.83 on Friday. Intuitive Surgical, Inc. has a 52 week low of $425.00 and a 52 week high of $616.00. The company’s fifty day moving average is $478.10 and its 200-day moving average is $504.94. The company has a market capitalization of $156.24 billion, a PE ratio of 60.79, a P/E/G ratio of 4.55 and a beta of 1.61.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.93 by $0.26. The business had revenue of $2.44 billion for the quarter, compared to the consensus estimate of $2.35 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. The firm’s quarterly revenue was up 21.4% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.78 EPS. On average, analysts forecast that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Insider Buying and Selling

In related news, Director Amy L. Ladd sold 336 shares of the company’s stock in a transaction dated Wednesday, September 3rd. The shares were sold at an average price of $470.11, for a total transaction of $157,956.96. Following the transaction, the director owned 1,074 shares in the company, valued at $504,898.14. This represents a 23.83% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Myriam Curet sold 4,500 shares of the company’s stock in a transaction dated Friday, July 25th. The stock was sold at an average price of $492.48, for a total transaction of $2,216,160.00. Following the transaction, the executive vice president owned 353 shares in the company, valued at approximately $173,845.44. This trade represents a 92.73% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 45,224 shares of company stock worth $21,716,492 in the last 90 days. Corporate insiders own 0.70% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts recently issued reports on ISRG shares. Zacks Research lowered shares of Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, August 20th. Piper Sandler reiterated an “overweight” rating and set a $595.00 price target (up previously from $575.00) on shares of Intuitive Surgical in a research note on Wednesday, July 23rd. Erste Group Bank reiterated a “hold” rating on shares of Intuitive Surgical in a research note on Wednesday, July 23rd. BTIG Research lifted their price target on shares of Intuitive Surgical from $566.00 to $571.00 and gave the stock a “buy” rating in a research note on Wednesday, July 23rd. Finally, Wall Street Zen upgraded shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a research note on Saturday, July 26th. Thirteen research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $595.95.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.